Page 59 - Demo

Methylphenidate for ADHD in Smith-Magenis syndrome573Trial registrationThis study is registered in the Netherlands Trial Register (NTR9125).Highlights of the study protocoly Innovative trial design combining collection of scientific data with personalized care, providing a much-needed bridge between practice and science.y Evidence-based treatment of ADHD symptoms in Smith–Magenis syndrome.y The first adequately powered series of randomized, doubleblind, placebo-controlled N-of-1 trials for a rare genetic neurodevelopmental disorder.y Exploring patient-centered outcome measures addressing relevant goals of the patient.Annelieke Muller sHL.indd 57 14-11-2023 09:07